The effect of doxapram on fetal rabbit ductus arteriosus

Hiroko Boda, Tadayoshi Hata, Hidetoshi Uchida, Masayuki Fujino, Yoshihiko Eryu, Masatomo Takeuchi, Masafumi Miyata, Hiroko Nomura, Toshio Yamazaki, Tetsushi Yoshikawa

Research output: Contribution to journalArticle

Abstract

Doxapram (DOP) is a respiratory stimulant that has been used as a second-line drug for the treatment of idiopathic apnea of prematurity unresponsive to methylxanthine therapy. The direct action of DOP on blood vessels is poorly understood. Furthermore, no reports have examined the effect of this therapy on the ductus arteriosus, a structure that frequently complicates low birth weight infants. To clarify the effects of the drug on the arterial vessel contractile system, we investigated the direct effect of DOP on the contractile profiles of the ductus arteriosus from fetal rabbit. The concentrations of doxapram used in clinical applications did not demonstrate any depressive or augmentative effects on the contractions of tissue preparations under hypoxic (PO2 30 mmHg) conditions. No relaxation of ductal tension was seen following DOP treatment after contraction by hyperoxia (PO 2 100-120 mmHg), indomethcin (1 μM), or high-K+ (120 mM). Our results indicate that therapeutic concentrations of DOP do not demonstrate any direct effects on the contractile mechanism of the ductus arteriosus in fetal rabbits.

Original languageEnglish
Pages (from-to)547-554
Number of pages8
JournalTherapeutic Research
Volume32
Issue number4
Publication statusPublished - 20-04-2011

Fingerprint

Doxapram
Ductus Arteriosus
Rabbits
Respiratory System Agents
Therapeutics
Hyperoxia
Low Birth Weight Infant
Apnea
Pharmaceutical Preparations
Blood Vessels

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Boda, H., Hata, T., Uchida, H., Fujino, M., Eryu, Y., Takeuchi, M., ... Yoshikawa, T. (2011). The effect of doxapram on fetal rabbit ductus arteriosus. Therapeutic Research, 32(4), 547-554.
Boda, Hiroko ; Hata, Tadayoshi ; Uchida, Hidetoshi ; Fujino, Masayuki ; Eryu, Yoshihiko ; Takeuchi, Masatomo ; Miyata, Masafumi ; Nomura, Hiroko ; Yamazaki, Toshio ; Yoshikawa, Tetsushi. / The effect of doxapram on fetal rabbit ductus arteriosus. In: Therapeutic Research. 2011 ; Vol. 32, No. 4. pp. 547-554.
@article{a298305681474b1781c83bf012576f99,
title = "The effect of doxapram on fetal rabbit ductus arteriosus",
abstract = "Doxapram (DOP) is a respiratory stimulant that has been used as a second-line drug for the treatment of idiopathic apnea of prematurity unresponsive to methylxanthine therapy. The direct action of DOP on blood vessels is poorly understood. Furthermore, no reports have examined the effect of this therapy on the ductus arteriosus, a structure that frequently complicates low birth weight infants. To clarify the effects of the drug on the arterial vessel contractile system, we investigated the direct effect of DOP on the contractile profiles of the ductus arteriosus from fetal rabbit. The concentrations of doxapram used in clinical applications did not demonstrate any depressive or augmentative effects on the contractions of tissue preparations under hypoxic (PO2 30 mmHg) conditions. No relaxation of ductal tension was seen following DOP treatment after contraction by hyperoxia (PO 2 100-120 mmHg), indomethcin (1 μM), or high-K+ (120 mM). Our results indicate that therapeutic concentrations of DOP do not demonstrate any direct effects on the contractile mechanism of the ductus arteriosus in fetal rabbits.",
author = "Hiroko Boda and Tadayoshi Hata and Hidetoshi Uchida and Masayuki Fujino and Yoshihiko Eryu and Masatomo Takeuchi and Masafumi Miyata and Hiroko Nomura and Toshio Yamazaki and Tetsushi Yoshikawa",
year = "2011",
month = "4",
day = "20",
language = "English",
volume = "32",
pages = "547--554",
journal = "Therapeutic Research",
issn = "0289-8020",
publisher = "Life Science Publishing Co. Ltd",
number = "4",

}

Boda, H, Hata, T, Uchida, H, Fujino, M, Eryu, Y, Takeuchi, M, Miyata, M, Nomura, H, Yamazaki, T & Yoshikawa, T 2011, 'The effect of doxapram on fetal rabbit ductus arteriosus', Therapeutic Research, vol. 32, no. 4, pp. 547-554.

The effect of doxapram on fetal rabbit ductus arteriosus. / Boda, Hiroko; Hata, Tadayoshi; Uchida, Hidetoshi; Fujino, Masayuki; Eryu, Yoshihiko; Takeuchi, Masatomo; Miyata, Masafumi; Nomura, Hiroko; Yamazaki, Toshio; Yoshikawa, Tetsushi.

In: Therapeutic Research, Vol. 32, No. 4, 20.04.2011, p. 547-554.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The effect of doxapram on fetal rabbit ductus arteriosus

AU - Boda, Hiroko

AU - Hata, Tadayoshi

AU - Uchida, Hidetoshi

AU - Fujino, Masayuki

AU - Eryu, Yoshihiko

AU - Takeuchi, Masatomo

AU - Miyata, Masafumi

AU - Nomura, Hiroko

AU - Yamazaki, Toshio

AU - Yoshikawa, Tetsushi

PY - 2011/4/20

Y1 - 2011/4/20

N2 - Doxapram (DOP) is a respiratory stimulant that has been used as a second-line drug for the treatment of idiopathic apnea of prematurity unresponsive to methylxanthine therapy. The direct action of DOP on blood vessels is poorly understood. Furthermore, no reports have examined the effect of this therapy on the ductus arteriosus, a structure that frequently complicates low birth weight infants. To clarify the effects of the drug on the arterial vessel contractile system, we investigated the direct effect of DOP on the contractile profiles of the ductus arteriosus from fetal rabbit. The concentrations of doxapram used in clinical applications did not demonstrate any depressive or augmentative effects on the contractions of tissue preparations under hypoxic (PO2 30 mmHg) conditions. No relaxation of ductal tension was seen following DOP treatment after contraction by hyperoxia (PO 2 100-120 mmHg), indomethcin (1 μM), or high-K+ (120 mM). Our results indicate that therapeutic concentrations of DOP do not demonstrate any direct effects on the contractile mechanism of the ductus arteriosus in fetal rabbits.

AB - Doxapram (DOP) is a respiratory stimulant that has been used as a second-line drug for the treatment of idiopathic apnea of prematurity unresponsive to methylxanthine therapy. The direct action of DOP on blood vessels is poorly understood. Furthermore, no reports have examined the effect of this therapy on the ductus arteriosus, a structure that frequently complicates low birth weight infants. To clarify the effects of the drug on the arterial vessel contractile system, we investigated the direct effect of DOP on the contractile profiles of the ductus arteriosus from fetal rabbit. The concentrations of doxapram used in clinical applications did not demonstrate any depressive or augmentative effects on the contractions of tissue preparations under hypoxic (PO2 30 mmHg) conditions. No relaxation of ductal tension was seen following DOP treatment after contraction by hyperoxia (PO 2 100-120 mmHg), indomethcin (1 μM), or high-K+ (120 mM). Our results indicate that therapeutic concentrations of DOP do not demonstrate any direct effects on the contractile mechanism of the ductus arteriosus in fetal rabbits.

UR - http://www.scopus.com/inward/record.url?scp=79956365881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956365881&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:79956365881

VL - 32

SP - 547

EP - 554

JO - Therapeutic Research

JF - Therapeutic Research

SN - 0289-8020

IS - 4

ER -

Boda H, Hata T, Uchida H, Fujino M, Eryu Y, Takeuchi M et al. The effect of doxapram on fetal rabbit ductus arteriosus. Therapeutic Research. 2011 Apr 20;32(4):547-554.